NVST Quote, Financials, Valuation and Earnings

Milestone Scientific, Inc. has a net margin of -4.52% compared to Envista Holdings Corp.'s net margin of -48.9%. Envista Holdings Corp.'s return on equity of 0.5% beat Milestone Scientific, Inc.'s return on equity of -142.42%.

Envista Holdings Corp. has a consensus price target of $22.31, signalling upside risk potential of 1.45%. On the other hand Milestone Scientific, Inc. has an analysts' consensus of $1.00 which suggests that it could grow by 245.07%. Given that Milestone Scientific, Inc. has higher upside potential than Envista Holdings Corp., analysts believe Milestone Scientific, Inc. is more attractive than Envista Holdings Corp..

Envista Holdings Corp. has a beta of 1.025, which suggesting that the stock is 2.453% more volatile than S&P 500. In comparison Milestone Scientific, Inc. has a beta of 0.937, suggesting its less volatile than the S&P 500 by 6.331%.

Envista Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings Corp. pays -- of its earnings as a dividend. Milestone Scientific, Inc. pays out -- of its earnings as a dividend.

Envista Holdings Corp. quarterly revenues are $669.9M, which are larger than Milestone Scientific, Inc. quarterly revenues of $2.4M. Envista Holdings Corp.'s net income of -$30.3M is lower than Milestone Scientific, Inc.'s net income of -$1.2M. Notably, Envista Holdings Corp.'s price-to-earnings ratio is 263.04x while Milestone Scientific, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings Corp. is 1.43x versus 2.63x for Milestone Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Solventum Corp. has a net margin of -4.52% compared to Envista Holdings Corp.'s net margin of 60.4%. Envista Holdings Corp.'s return on equity of 0.5% beat Solventum Corp.'s return on equity of 42.2%.

Envista Holdings Corp. has a consensus price target of $22.31, signalling upside risk potential of 1.45%. On the other hand Solventum Corp. has an analysts' consensus of $85.64 which suggests that it could grow by 6.43%. Given that Solventum Corp. has higher upside potential than Envista Holdings Corp., analysts believe Solventum Corp. is more attractive than Envista Holdings Corp..

Envista Holdings Corp. has a beta of 1.025, which suggesting that the stock is 2.453% more volatile than S&P 500. In comparison Solventum Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Envista Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solventum Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings Corp. pays -- of its earnings as a dividend. Solventum Corp. pays out -- of its earnings as a dividend.

Envista Holdings Corp. quarterly revenues are $669.9M, which are smaller than Solventum Corp. quarterly revenues of $2.1B. Envista Holdings Corp.'s net income of -$30.3M is lower than Solventum Corp.'s net income of $1.3B. Notably, Envista Holdings Corp.'s price-to-earnings ratio is 263.04x while Solventum Corp.'s PE ratio is 9.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings Corp. is 1.43x versus 1.67x for Solventum Corp.. Usually stocks with elevated PS ratios are considered overvalued.

West Pharmaceutical Services, Inc. has a net margin of -4.52% compared to Envista Holdings Corp.'s net margin of 17.41%. Envista Holdings Corp.'s return on equity of 0.5% beat West Pharmaceutical Services, Inc.'s return on equity of 17.44%.

Envista Holdings Corp. has a consensus price target of $22.31, signalling upside risk potential of 1.45%. On the other hand West Pharmaceutical Services, Inc. has an analysts' consensus of $345.71 which suggests that it could grow by 26.04%. Given that West Pharmaceutical Services, Inc. has higher upside potential than Envista Holdings Corp., analysts believe West Pharmaceutical Services, Inc. is more attractive than Envista Holdings Corp..

Envista Holdings Corp. has a beta of 1.025, which suggesting that the stock is 2.453% more volatile than S&P 500. In comparison West Pharmaceutical Services, Inc. has a beta of 1.166, suggesting its more volatile than the S&P 500 by 16.617%.

Envista Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. West Pharmaceutical Services, Inc. offers a yield of 0.31% to investors and pays a quarterly dividend of $0.22 per share. Envista Holdings Corp. pays -- of its earnings as a dividend. West Pharmaceutical Services, Inc. pays out 12.27% of its earnings as a dividend. West Pharmaceutical Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Envista Holdings Corp. quarterly revenues are $669.9M, which are smaller than West Pharmaceutical Services, Inc. quarterly revenues of $804.3M. Envista Holdings Corp.'s net income of -$30.3M is lower than West Pharmaceutical Services, Inc.'s net income of $140M. Notably, Envista Holdings Corp.'s price-to-earnings ratio is 263.04x while West Pharmaceutical Services, Inc.'s PE ratio is 40.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings Corp. is 1.43x versus 6.62x for West Pharmaceutical Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona, Inc. has a net margin of -4.52% compared to Envista Holdings Corp.'s net margin of -47.35%. Envista Holdings Corp.'s return on equity of 0.5% beat Dentsply Sirona, Inc.'s return on equity of -44.58%.

Envista Holdings Corp. has a consensus price target of $22.31, signalling upside risk potential of 1.45%. On the other hand Dentsply Sirona, Inc. has an analysts' consensus of $12.77 which suggests that it could grow by 10.82%. Given that Dentsply Sirona, Inc. has higher upside potential than Envista Holdings Corp., analysts believe Dentsply Sirona, Inc. is more attractive than Envista Holdings Corp..

Envista Holdings Corp. has a beta of 1.025, which suggesting that the stock is 2.453% more volatile than S&P 500. In comparison Dentsply Sirona, Inc. has a beta of 1.008, suggesting its more volatile than the S&P 500 by 0.82100000000001%.

Envista Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona, Inc. offers a yield of 5.56% to investors and pays a quarterly dividend of $0.16 per share. Envista Holdings Corp. pays -- of its earnings as a dividend. Dentsply Sirona, Inc. pays out 13.85% of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Envista Holdings Corp. quarterly revenues are $669.9M, which are smaller than Dentsply Sirona, Inc. quarterly revenues of $904M. Envista Holdings Corp.'s net income of -$30.3M is higher than Dentsply Sirona, Inc.'s net income of -$428M. Notably, Envista Holdings Corp.'s price-to-earnings ratio is 263.04x while Dentsply Sirona, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings Corp. is 1.43x versus 0.63x for Dentsply Sirona, Inc.. Usually stocks with elevated PS ratios are considered overvalued.